rfhg_140238.1

Basic information about the TSS

---

TSS ID: rfhg_140238.1 TSS ID(Version3): hg_115516.1 hg_115515.1 Species: human Chr: chr11		Start: 68030616 End: 68030744 Strand: +
Source datasets	FANTOM5|EPD|ENCODE|PRJNA401781|PRJNA548673|PRJNA615891 |PRJNA4843412|DRA013844|PRJDB5282|PRJNA597322
Protocol	CAGE|TSS_database|RAMPAGE|oligo_capping|ReCappable-seq |TIF-seq2|SLIC_CAGE|NETCAGE|C1CAGE|STRIPE-seq
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2462708,EH38E1547573)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000432321.6:0 ENST00000531796.1:0 ENST00000453471.6:0 ENST00000313468.10:0 ENST00000526446.5:0 ENST00000528492.1:0 ENST00000532399.1:0 ENST00000531228.1:0 ENST00000526339.5:0 AK302449:0 AK223114:0 BC119753:0 BC119754:0 AK314546:0 U65579:0 AK002110:0 GeneID: 4728 HGNC/MGI_ID: HGNC:7715 UniProt_ID: B4DYI3 E9PJY7 E9PML5 E9PPW7 F8W9K7 O00217 Q08E91 Q53G17 Nearer transcript ids and distances: ENST00000525419.5:16 LF344198:47 MA579775:47 ENST00000525628.1:222 view more...

Gene_name: NADH:ubiquinone oxidoreductase core subunit S8 Gene_symbol: NDUFS8 Gene_synonyms: CI-23k TYKY Gene_source: HGNC:7715

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_002496
Entrez ID:	4728
Nearest Unigene:	Hs.90443
Nearest Refseq:	NM_002496
Nearest Ensembl:	ENSG00000110717
Gene Name:	NADH:ubiquinone oxidoreductase core subunit S8
Gene Alias:	CI-23k|CI23KD|MC1DN2|TYKY
Gene Type:	protein-coding
CpG%:	0.054688
GC%:	0.596899
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NDUFS8 p2@NDUFS8 p3@NDUFS8 p4@NDUFS8 p5@NDUFS8
Sample		p1@NDUFS8	p2@NDUFS8	p3@NDUFS8	p4@NDUFS8	p5@NDUFS8
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	190.71	2.34	0.39	1.75	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	199.49	1.62	0.40	2.02	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	179.59	1.93	0.39	1.74	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	169.45	1.25	0.21	0.83	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	172.55	1.35	0.45	1.12	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	177.92	0.97	0.39	1.94	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	221.15	3.70	1.53	1.74	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	210.25	2.18	0.48	2.18	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	246.63	1.07	0.85	2.56	1.50
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	179.10	2.32	0.00	4.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	164.12	0.40	0.00	4.04	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	152.05	2.85	0.41	2.85	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	100.10	1.93	0.32	2.90	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	91.56	3.01	1.20	2.41	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	92.21	1.98	1.54	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	95.31	1.01	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	93.70	1.97	0.66	2.84	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	82.25	0.84	1.69	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	86.90	1.60	1.07	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	89.66	3.31	0.90	2.56	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	88.88	2.14	0.27	2.54	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	82.86	2.76	0.86	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	85.83	2.20	0.78	2.59	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	89.06	1.94	0.00	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	81.52	3.10	0.77	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	87.67	2.22	0.63	1.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	86.81	0.55	1.10	2.75	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	91.71	2.36	1.18	2.36	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	88.03	2.26	0.48	1.94	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	81.25	2.53	1.45	2.17	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	95.04	2.09	0.21	1.47	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	90.27	2.15	0.39	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	96.02	1.90	1.06	1.90	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	86.92	2.47	0.49	1.81	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	84.71	1.68	0.37	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	82.97	1.34	0.77	2.30	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	87.07	1.84	0.82	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	94.30	2.01	0.40	1.41	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	87.51	1.89	0.54	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	88.34	2.64	0.48	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	100.22	1.88	0.71	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	81.83	1.90	0.73	2.20	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	83.09	1.27	0.42	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	84.44	2.10	0.87	1.22	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	83.12	3.61	0.80	2.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	82.82	0.93	0.47	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	82.05	1.20	0.96	1.92	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	77.79	2.09	0.30	1.79	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	90.00	1.44	1.20	1.68	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	78.25	1.82	0.81	2.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	76.45	1.23	0.00	1.02	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	102.29	1.33	0.44	1.56	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	126.33	3.55	0.35	1.42	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	112.34	1.66	0.66	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	47.82	1.68	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	58.78	0.46	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	114.73	3.24	0.00	1.30	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	109.20	1.93	0.64	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	68.52	0.94	0.63	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	119.86	2.12	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	136.83	2.24	1.68	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	45.38	2.39	0.00	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	84.60	2.38	0.34	0.00	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	106.57	3.25	1.30	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	128.50	2.84	0.71	2.13	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	142.35	2.93	0.49	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	138.84	1.98	0.00	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	125.25	2.35	0.47	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	111.94	0.66	0.66	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	146.01	2.78	0.31	0.31	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	161.13	1.83	1.53	1.22	2.75
Adipocyte - breast, donor1	11376-118A8	105.33	1.27	1.27	1.11	0.32
Adipocyte - breast, donor2	11327-117E4	147.27	2.41	1.93	1.12	0.16
Adipocyte - omental, donor1	11473-119C6	125.83	2.29	1.91	0.89	0.38
Adipocyte - omental, donor2	11474-119C7	148.75	2.24	1.49	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	147.03	0.00	1.34	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	130.79	0.64	0.64	3.83	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	168.22	3.30	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	164.39	0.45	1.35	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	186.64	2.09	2.26	0.87	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	142.38	2.74	1.37	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	99.86	2.06	0.51	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	142.45	2.23	0.56	2.23	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	169.88	1.76	0.00	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	265.91	6.76	3.54	1.05	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	152.34	1.61	0.65	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	129.03	2.13	0.00	0.53	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	227.03	0.56	0.56	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	274.90	4.16	2.50	1.25	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	180.34	2.01	1.76	1.51	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	209.44	2.29	0.33	1.31	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	203.08	2.13	0.30	0.61	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	213.26	1.10	1.99	3.09	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	422.77	6.10	2.51	4.66	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	111.42	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	170.19	2.34	0.90	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	152.29	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	151.00	2.67	1.44	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	155.05	1.72	1.03	1.37	0.00
Anulus Pulposus Cell, donor2	11463-119B5	126.62	0.24	0.98	4.16	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	126.25	2.25	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	157.59	3.47	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	132.70	2.14	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	130.33	2.39	0.30	1.20	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	147.96	1.26	0.00	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	134.65	1.98	0.66	1.32	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	146.20	0.97	1.30	1.30	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	155.83	3.88	0.49	2.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	146.09	1.19	1.78	3.56	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	140.86	1.51	1.51	2.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	142.23	2.90	1.45	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	151.71	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	185.16	3.13	2.97	2.31	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	165.14	4.09	4.09	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	155.92	1.96	1.81	1.51	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	139.30	2.68	1.61	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	144.16	1.51	2.27	0.94	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	149.41	1.34	1.60	1.07	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	133.64	3.90	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	136.83	2.16	1.66	1.16	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	134.48	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	145.15	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	148.54	2.06	1.03	1.20	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	121.65	4.19	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	136.40	1.46	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	146.85	1.52	1.14	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	140.52	2.42	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	138.52	1.71	1.14	2.28	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	157.98	2.78	2.14	2.14	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	138.34	1.55	1.29	1.55	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	156.71	1.88	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	142.12	0.96	0.96	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	136.27	0.71	0.71	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	138.63	1.17	1.75	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	142.41	2.71	0.60	3.01	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	160.38	3.56	1.19	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	161.21	2.54	1.53	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	142.88	3.57	1.53	0.51	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	156.30	3.18	1.27	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	143.27	3.02	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	144.58	2.75	2.33	1.06	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	135.71	3.19	1.45	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	149.27	4.72	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	146.98	2.88	1.36	2.37	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	141.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	133.09	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	150.09	2.79	2.57	0.86	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	141.99	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	131.22	1.46	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	142.76	3.91	3.22	1.38	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	150.47	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	162.71	2.03	1.02	1.53	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	163.29	3.10	1.86	1.86	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	131.89	0.92	1.22	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	138.62	1.91	0.00	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	145.46	1.77	2.66	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	184.62	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	135.15	3.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	135.57	1.59	1.32	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	145.38	2.18	1.09	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	272.16	2.46	0.86	1.72	0.00
Astrocyte - cerebellum, donor2	11580-120F5	299.70	3.42	1.20	2.05	0.51
Astrocyte - cerebellum, donor3	11661-122F5	177.66	3.99	0.84	1.89	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	185.80	4.53	1.39	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	214.51	2.91	2.26	1.62	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	184.06	4.77	0.75	1.34	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	161.59	5.39	0.34	1.15	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	171.64	5.89	0.88	1.50	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	151.12	4.10	0.46	0.57	0.80
Basophils, donor1	12241-129G9	36.88	0.78	0.52	0.26	0.26
Basophils, donor2	12242-129H1	38.97	1.44	0.36	0.00	0.00
Basophils, donor3	12243-129H2	64.97	2.06	0.00	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	151.78	3.88	4.53	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	304.03	4.11	1.37	1.83	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	136.30	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	185.16	3.14	0.63	1.26	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	192.77	4.78	2.08	0.62	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	186.30	3.45	1.15	2.07	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	124.34	4.50	1.62	1.26	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	233.42	2.47	1.75	0.62	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	183.99	3.49	1.16	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	163.09	3.84	1.92	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	52.97	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	43.24	0.56	0.19	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	49.62	1.10	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	102.18	4.53	0.85	1.42	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	125.85	3.79	0.76	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	98.95	3.29	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	41.63	1.01	0.00	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	47.68	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	41.69	0.00	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	32.31	0.33	0.00	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.85	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	36.20	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	37.20	0.78	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	39.53	0.36	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	51.80	0.65	0.44	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	33.01	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	37.93	0.89	0.15	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	37.91	0.80	0.00	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	36.43	0.83	0.21	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.38	0.69	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	35.51	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	30.55	1.31	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	47.34	1.08	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	47.98	0.35	0.17	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.07	1.26	0.00	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.64	1.29	0.18	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.70	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	31.15	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	34.87	0.70	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	49.80	0.74	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	54.53	0.65	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	38.08	0.82	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.93	0.00	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	40.13	0.46	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	98.30	0.65	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	89.16	2.08	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	123.47	2.82	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	131.74	2.02	0.00	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	91.86	1.75	0.17	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	81.61	0.45	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	90.08	2.55	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	65.21	1.32	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	75.38	0.84	0.84	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	71.13	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	75.26	4.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	64.21	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	85.29	2.67	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	69.15	4.29	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	70.90	1.40	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	82.36	2.35	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	90.96	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.03	0.82	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	49.33	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	52.50	0.50	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	238.39	4.44	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	230.11	6.79	1.60	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	98.40	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	47.75	0.56	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	200.28	2.63	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	200.91	5.19	0.90	0.45	0.23
CD4+ T Cells, donor1	11225-116C1	64.63	2.14	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	72.26	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	69.84	1.22	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	133.74	1.79	1.28	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	143.29	3.37	0.67	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	137.98	2.30	0.86	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	109.99	2.84	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	128.52	2.11	0.70	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	128.55	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	133.39	1.45	0.29	0.43	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	124.05	2.54	0.00	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	113.49	1.29	0.16	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	118.80	1.34	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	144.30	3.49	0.35	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	90.20	1.32	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	155.59	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	141.28	3.32	0.62	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	155.70	3.68	0.67	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	139.23	1.63	0.27	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	118.98	1.07	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	161.39	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	161.14	2.97	0.56	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	146.87	3.47	1.52	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	167.70	3.15	1.26	0.21	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	127.41	2.53	0.51	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	114.38	3.03	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	68.86	1.31	0.44	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	126.69	3.46	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	144.94	5.54	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	128.42	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	120.19	1.11	0.00	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	116.56	1.23	0.00	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	118.58	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	106.36	3.94	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	135.73	9.69	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	73.99	0.98	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	57.44	1.13	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	66.66	3.28	0.00	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	144.98	1.84	0.23	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	129.89	3.12	0.72	0.96	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	118.74	0.55	0.55	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	144.70	1.50	0.00	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	148.31	1.20	0.24	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	134.38	1.14	0.00	1.14	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	172.09	0.87	0.43	1.96	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	171.87	1.05	0.53	1.84	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	174.71	0.47	0.00	1.64	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	204.07	3.02	0.60	2.72	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	177.79	1.45	0.87	0.87	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	191.57	1.33	0.00	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	90.18	0.00	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	82.89	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	67.87	0.00	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	135.06	1.80	0.36	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	128.32	2.30	0.00	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	119.73	1.41	0.71	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	199.65	1.27	0.63	1.58	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	179.31	0.92	0.31	1.85	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	169.59	1.92	0.32	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	181.67	2.29	0.76	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	156.07	1.58	0.39	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	176.24	0.76	0.00	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	97.96	0.80	0.00	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	71.34	2.10	0.70	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	106.19	2.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	42.04	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	169.47	2.96	0.99	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	117.86	5.16	1.68	0.95	0.21
Chondrocyte - de diff, donor1	11261-116G1	147.68	0.69	1.39	2.08	0.35
Chondrocyte - de diff, donor2	11338-117F6	143.93	2.13	1.07	1.78	0.00
Chondrocyte - de diff, donor3	11410-118E6	125.50	2.73	2.16	1.71	0.11
Chondrocyte - re diff, donor2	11339-117F7	264.10	2.69	4.48	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	94.23	3.24	0.81	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	183.15	5.05	2.87	1.72	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	160.97	5.77	1.28	1.92	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	175.67	3.54	2.39	1.24	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	162.95	10.18	1.65	11.74	0.18
Corneal Epithelial Cells, donor1	11526-119I5	231.21	4.17	1.10	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	216.14	4.55	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	196.32	6.14	2.05	1.28	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	101.86	3.14	0.50	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	105.66	3.47	1.58	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	89.72	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	107.13	3.24	1.84	0.43	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	56.03	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	84.22	3.26	1.31	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	56.62	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	128.08	6.00	1.00	0.83	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	159.02	2.93	0.59	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	167.98	3.96	0.85	1.70	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	121.49	4.72	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	177.14	4.94	1.16	1.75	0.58
Endothelial Cells - Artery, donor2	11341-117F9	206.10	4.24	1.41	2.59	1.65
Endothelial Cells - Artery, donor3	11413-118E9	164.44	4.91	1.93	1.40	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	109.05	2.44	0.44	1.33	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	110.14	4.56	0.91	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	100.64	3.38	0.56	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	161.34	4.46	0.59	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	185.88	2.60	0.52	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	117.82	4.68	0.99	1.28	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	201.66	2.40	0.00	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	156.19	3.67	1.57	1.57	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	188.11	2.24	2.24	0.25	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	138.18	1.30	1.74	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	170.12	3.05	1.47	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	250.25	9.10	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	234.70	1.40	0.70	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	171.77	4.71	2.20	1.73	0.47
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	23.10	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	156.61	3.18	1.95	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	158.09	0.00	0.00	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	91.96	1.64	0.82	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	88.36	2.96	1.42	1.20	1.97
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	154.71	1.95	2.06	1.52	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	108.06	2.67	2.06	1.82	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	55.54	0.82	0.68	1.23	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	108.11	2.21	1.58	1.48	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	62.71	0.79	0.26	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	132.88	2.33	1.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	186.44	2.72	3.18	1.36	0.91
Fibroblast - Cardiac, donor2	11345-117G4	154.62	7.58	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	224.59	6.31	2.68	2.21	2.05
Fibroblast - Cardiac, donor4	11452-119A3	106.09	1.82	0.61	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	118.91	1.78	1.14	0.76	0.89
Fibroblast - Cardiac, donor6	11460-119B2	109.91	0.61	1.52	1.36	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	177.14	1.47	1.07	0.67	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	115.62	1.73	0.43	1.73	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	246.09	10.25	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	308.59	3.69	2.54	1.15	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	92.10	1.19	1.36	1.19	0.17
Fibroblast - Dermal, donor1	11269-116G9	164.58	4.23	2.58	1.41	0.70
Fibroblast - Dermal, donor2	11346-117G5	239.61	3.77	1.42	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	143.25	2.66	2.06	1.09	0.24
Fibroblast - Dermal, donor4	11450-119A1	169.91	1.58	1.24	0.23	0.45
Fibroblast - Dermal, donor5	11454-119A5	167.65	1.22	0.70	0.70	0.70
Fibroblast - Dermal, donor6	11458-119A9	183.54	0.81	0.49	0.97	0.97
Fibroblast - Gingival, donor1	11237-116D4	148.68	2.92	2.71	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	132.83	2.36	1.31	2.10	1.57
Fibroblast - Gingival, donor2	11318-117D4	198.47	4.35	2.11	0.26	0.53
Fibroblast - Gingival, donor3	11394-118C8	157.41	2.32	2.22	1.16	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	129.86	1.04	2.08	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	93.04	2.47	0.88	1.59	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	148.73	2.81	1.25	0.94	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	156.86	2.84	1.22	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	186.67	3.18	2.47	1.76	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	128.11	3.22	0.73	1.02	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	139.63	2.59	1.50	0.68	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	136.46	3.62	1.86	1.10	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	68.67	1.76	0.73	1.32	1.17
Fibroblast - Lung, donor1	11270-116H1	304.49	4.08	5.44	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	164.14	1.49	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	271.81	3.17	0.42	1.69	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	323.21	2.50	2.50	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	208.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	196.75	1.96	0.84	1.40	0.28
Fibroblast - Mammary, donor1	11540-120B1	275.65	4.87	1.62	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	255.63	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	95.30	5.96	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	150.72	4.27	1.55	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	190.51	6.37	1.67	0.61	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	179.61	5.51	1.53	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	137.00	4.58	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	147.41	4.05	1.62	1.08	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	107.04	2.44	0.46	2.09	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	131.53	3.76	2.10	0.88	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	278.57	4.88	0.81	1.42	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	193.11	4.68	2.00	0.67	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	192.15	4.74	1.19	1.98	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	74.81	0.20	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	91.83	1.78	0.53	2.49	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	116.08	1.18	1.38	1.58	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	81.83	0.30	0.60	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	117.24	1.51	0.97	0.97	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	82.76	0.51	0.51	2.28	0.25
Fibroblast - skin normal, donor1	11553-120C5	155.38	1.64	1.97	0.98	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	58.75	1.00	1.20	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	106.79	1.81	0.70	1.21	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	83.72	0.91	0.91	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	100.99	2.07	1.41	1.99	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	99.84	1.71	0.85	1.54	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	83.75	0.99	0.99	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	155.31	1.81	1.92	1.38	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	179.65	3.20	1.01	1.86	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	97.23	2.04	0.47	0.94	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	82.80	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	119.10	2.95	1.91	1.91	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	113.20	3.38	3.38	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	98.88	4.85	2.30	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	258.76	0.77	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	289.05	1.91	1.91	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	159.75	3.71	3.42	1.14	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	153.60	11.31	1.10	0.28	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	105.03	4.57	0.00	0.23	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	172.97	3.37	1.78	0.79	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	148.82	6.87	1.32	0.53	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	123.61	5.87	0.00	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	177.77	1.33	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	191.63	2.12	0.85	1.13	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	198.26	2.22	1.23	1.60	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	223.76	1.88	2.95	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	209.13	1.73	1.36	1.86	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	217.05	1.66	0.69	1.38	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	214.48	2.03	1.22	0.81	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	242.10	1.60	2.28	1.37	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	187.22	1.12	1.00	1.49	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	176.61	1.53	1.75	0.87	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	293.71	1.77	2.07	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	216.66	2.23	0.16	0.95	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	260.73	3.35	3.35	0.89	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	229.66	2.22	1.21	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	200.01	1.53	1.19	1.53	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	241.54	1.86	2.48	0.98	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	351.09	2.19	3.54	1.56	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	372.98	2.22	1.71	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	185.90	2.43	1.00	1.33	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	215.89	1.83	1.83	1.16	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	248.90	1.02	2.65	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	231.06	1.86	2.68	1.44	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	189.20	0.92	0.69	0.92	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	225.97	2.50	1.17	1.33	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	226.60	1.98	1.54	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	208.47	1.11	1.11	1.11	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	209.75	3.24	1.95	0.81	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	240.54	2.57	1.60	3.85	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	167.24	1.52	0.76	1.52	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	207.84	1.27	1.27	1.58	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	209.21	2.13	3.34	1.52	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	173.22	1.46	1.05	1.15	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	202.21	1.54	1.54	2.20	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	220.79	2.52	1.68	1.40	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	142.77	1.48	0.19	0.65	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	228.90	2.41	1.34	1.34	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	184.83	1.84	2.60	0.77	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	179.54	1.55	1.68	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	213.33	2.98	2.44	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	203.52	1.47	3.32	1.29	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	190.14	0.88	1.75	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	211.24	0.99	2.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	205.12	2.64	3.56	0.79	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	175.53	0.81	1.21	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	203.33	2.29	3.30	2.03	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	238.67	1.19	2.19	1.39	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	216.48	1.69	2.00	0.77	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	245.09	2.66	1.02	1.02	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	291.34	4.69	2.50	2.82	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	313.35	5.65	1.13	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	193.24	4.15	0.46	0.00	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	257.38	0.00	0.00	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	209.65	3.87	2.32	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	338.54	3.21	0.00	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	252.13	6.96	0.00	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	203.75	3.25	1.63	1.30	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	198.90	4.12	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	219.93	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	194.91	2.80	1.40	1.40	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	204.93	3.27	0.98	0.33	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	205.51	5.03	0.84	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	221.38	5.73	1.27	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	243.20	4.76	0.68	2.04	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	248.49	8.35	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	294.37	3.44	1.15	2.86	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	250.40	1.78	0.30	1.78	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	215.16	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	238.17	6.21	0.00	4.56	3.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	235.88	4.60	1.38	1.15	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	295.04	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	182.98	2.69	0.38	1.92	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	208.30	4.24	2.28	3.26	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	212.69	6.02	1.34	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	266.99	3.47	1.54	3.47	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	212.59	3.08	0.34	4.79	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	206.24	2.48	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	251.02	2.36	0.47	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	253.47	4.22	0.60	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	224.33	3.05	0.51	2.03	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	248.88	6.38	0.40	1.20	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	223.98	1.97	0.00	2.96	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	229.01	1.18	1.18	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	263.72	3.50	0.00	2.92	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	279.13	3.95	0.44	5.71	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	183.10	2.54	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	189.22	4.18	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	189.73	3.40	0.00	2.43	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	252.23	4.57	3.42	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	226.62	3.33	0.42	2.08	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	375.57	6.75	6.75	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	113.23	0.32	1.59	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	116.55	2.92	0.84	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	284.19	4.76	3.02	0.81	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	316.84	2.70	2.36	1.18	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	265.95	3.41	3.64	1.14	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	285.73	4.04	2.51	1.31	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	304.10	3.01	3.87	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	259.41	3.23	3.23	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	309.85	4.11	2.86	1.99	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	302.44	2.74	3.43	1.72	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	287.05	2.88	2.24	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	183.56	3.36	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	167.92	1.73	0.43	1.73	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	182.42	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	186.59	3.17	0.71	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	136.58	0.73	2.91	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	153.16	2.97	1.40	1.05	0.87
Hepatocyte, donor1	11523-119I2	148.90	2.42	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	133.59	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	95.10	3.07	0.61	1.23	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	167.74	4.57	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	311.64	13.63	4.19	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	162.04	6.04	1.65	1.10	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	579.47	22.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	660.86	13.35	0.00	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	622.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	568.98	8.31	1.38	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	640.68	12.51	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	664.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	527.96	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	598.77	18.28	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	669.22	14.62	0.00	3.25	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	536.87	6.67	1.67	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	497.39	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	578.36	9.26	2.65	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	524.39	9.98	2.22	2.22	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	660.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	424.53	9.45	0.63	3.15	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	477.91	12.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	307.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	531.04	3.23	0.65	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	589.23	14.49	3.22	4.83	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	501.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	575.30	6.52	0.81	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	617.54	14.27	1.26	2.52	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	373.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	456.49	8.04	2.41	5.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	441.33	8.31	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	331.78	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	423.89	5.19	0.47	1.89	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	447.14	8.16	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	398.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	497.17	9.69	2.15	6.46	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	597.12	20.33	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	558.63	32.86	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	506.32	6.38	0.64	3.19	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	634.29	9.11	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	474.13	0.00	0.00	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	453.43	2.86	3.57	0.71	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	647.07	9.95	0.00	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	479.52	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	359.28	5.25	1.23	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	642.70	3.51	1.76	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	609.77	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	453.39	9.74	0.70	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	896.30	8.85	4.43	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	479.82	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	578.09	4.36	1.74	1.74	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	762.68	9.00	2.25	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	738.73	10.45	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	634.73	10.67	4.27	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	655.31	5.54	0.00	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	604.12	5.70	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	597.36	12.89	2.76	2.76	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	671.62	21.18	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	769.88	18.63	6.21	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	655.57	20.09	3.17	3.17	3.17
Keratinocyte - epidermal, donor1	11272-116H3	145.98	2.61	3.10	1.14	0.08
Keratinocyte - epidermal, donor2	11349-117G8	230.15	5.86	0.00	1.76	1.17
Keratinocyte - epidermal, donor3	11421-118F8	148.04	2.93	2.08	1.14	0.19
Keratinocyte - oral, donor1	11251-116E9	169.71	5.90	2.72	1.48	0.34
Keratocytes, donor1	11527-119I6	331.11	6.88	0.69	1.72	0.00
Keratocytes, donor2	11607-120I5	193.35	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	160.84	7.31	1.78	1.38	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	107.70	8.79	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	186.62	6.47	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	208.75	7.38	2.19	2.31	0.12
Lens Epithelial Cells, donor3	11690-122I7	114.53	4.84	1.11	1.11	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	125.57	4.98	0.95	1.42	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	111.63	4.19	0.84	1.40	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	119.16	1.73	0.79	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	111.84	3.76	0.54	2.15	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	128.59	3.15	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	128.62	2.48	1.29	1.19	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	100.96	3.69	0.41	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	137.53	3.03	0.00	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	127.94	1.97	0.00	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	87.02	1.98	1.19	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	109.74	2.52	0.78	0.97	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	144.60	3.33	1.11	1.30	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	111.84	2.44	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	132.38	3.58	0.72	1.19	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	123.20	2.33	0.69	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	93.62	0.92	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	130.93	3.43	0.62	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	154.08	1.83	0.55	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	121.44	1.65	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	125.93	2.93	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	165.29	2.49	1.24	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	115.91	3.39	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	101.79	2.42	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	124.58	2.12	0.30	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	110.42	1.56	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	104.28	2.30	0.63	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	121.20	3.01	0.45	0.90	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	95.61	2.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	101.79	2.82	0.19	0.94	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	120.45	3.07	0.42	0.85	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	105.64	0.97	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	98.58	1.32	0.00	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	143.22	2.60	0.99	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	122.91	1.48	0.00	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	98.83	1.98	0.49	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	143.54	2.20	0.55	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	102.60	1.61	1.29	1.93	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	90.08	2.43	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	123.59	2.52	0.56	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	107.02	1.78	0.36	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	95.50	2.42	0.00	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	161.05	3.42	0.93	1.09	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	120.68	2.86	1.07	1.43	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	92.78	1.96	0.00	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	145.26	3.53	0.24	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	114.47	3.47	0.37	1.61	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	106.29	2.82	0.51	1.02	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	136.35	3.28	1.49	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	224.33	9.06	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	303.78	11.51	4.60	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	307.28	11.13	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	296.61	4.65	0.85	1.27	2.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	303.84	15.47	4.22	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	344.63	14.94	2.80	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	230.33	2.06	0.52	1.55	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	317.59	10.71	2.38	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	283.42	13.57	2.49	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	179.44	3.78	0.87	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	235.89	10.35	1.80	2.25	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	323.81	13.28	3.12	0.81	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	232.63	3.08	1.03	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	213.83	8.47	0.71	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	221.21	8.66	1.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	237.37	3.57	0.51	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	235.59	10.41	1.60	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	210.86	7.56	1.13	0.76	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	262.60	7.36	3.07	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	290.29	10.60	1.63	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	187.21	6.25	2.50	0.83	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	187.77	5.04	0.28	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	243.16	9.27	2.06	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	206.41	6.68	0.58	0.58	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	201.78	2.39	1.20	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	236.24	8.30	3.32	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	286.32	14.49	2.83	0.71	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	224.96	5.53	0.74	0.74	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	252.13	5.76	0.00	3.45	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	282.83	6.14	0.77	1.92	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	244.00	2.83	2.26	1.13	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	297.83	10.67	3.28	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	268.87	11.75	2.71	2.71	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	239.14	5.03	1.44	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	291.29	14.19	2.24	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	246.74	10.03	1.49	1.86	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	236.05	5.17	2.15	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	280.01	17.98	2.57	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	276.54	12.66	1.00	3.00	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	266.06	5.43	0.60	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	322.08	12.80	1.42	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	255.73	7.91	1.03	1.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	269.98	6.98	0.00	0.54	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	305.03	8.75	4.71	2.02	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	278.18	10.37	1.48	1.48	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	172.11	13.96	1.16	3.49	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	323.67	11.64	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	246.89	8.80	1.60	2.00	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	278.39	5.09	1.45	4.36	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	340.33	12.26	3.07	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	306.33	6.91	0.49	1.48	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	247.46	5.65	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	338.90	12.07	1.51	1.51	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	297.86	15.77	1.35	1.80	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	266.77	1.72	3.44	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	323.32	12.02	4.01	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	280.37	6.26	0.39	1.17	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	226.95	3.30	1.32	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	310.84	10.90	3.11	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	210.91	12.69	0.00	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	230.35	5.59	0.56	1.12	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	283.09	15.02	1.32	2.21	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	230.27	8.10	1.16	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	194.95	6.58	1.01	2.53	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	260.50	9.61	2.40	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	258.41	12.72	1.19	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	210.84	2.43	0.00	1.22	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	260.08	2.08	0.69	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	242.43	7.60	1.90	1.52	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	219.99	6.71	0.52	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	289.63	6.05	3.02	3.02	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	245.92	7.61	2.22	1.27	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	241.49	4.26	1.07	0.53	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	302.85	5.75	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	276.14	9.26	1.03	1.03	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	263.84	6.37	0.00	2.83	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	341.06	5.67	3.97	2.27	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	292.47	10.82	0.83	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	260.75	3.13	1.57	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	334.04	6.26	1.25	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	312.24	6.50	1.86	2.32	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	278.32	6.02	0.67	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	340.03	3.21	0.53	2.14	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	273.98	10.51	2.02	0.40	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	257.89	4.59	2.75	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	349.42	2.67	2.67	1.78	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	324.26	9.12	2.28	1.71	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	330.53	6.14	1.53	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	334.87	7.11	1.09	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	322.95	14.25	1.34	3.12	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	336.64	11.96	1.82	1.82	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	364.05	3.98	1.33	1.99	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	417.80	14.55	0.00	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	72.71	2.28	0.68	0.91	0.23
Macrophage - monocyte derived, donor2	11313-117C8	149.74	5.51	2.75	1.47	0.18
Macrophage - monocyte derived, donor3	11389-118C3	114.17	3.67	1.05	0.52	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	143.91	8.50	0.53	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	103.15	4.91	0.79	2.06	0.16
Mallassez-derived cells, donor3	11930-125I4	118.00	2.50	1.53	0.97	0.56
Mammary Epithelial Cell, donor1	11273-116H4	115.39	2.59	2.69	1.99	0.30
Mammary Epithelial Cell, donor2	11350-117G9	149.41	2.32	3.19	2.03	0.00
Mammary Epithelial Cell, donor3	11422-118F9	180.58	2.99	1.50	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	203.38	4.75	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	145.67	4.87	0.65	0.65	0.00
Mast cell, donor2	11565-120D8	54.98	2.08	0.00	0.89	0.59
Mast cell, donor3	11566-120D9	40.75	1.35	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	61.87	1.24	0.35	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	126.42	4.44	0.55	0.67	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	121.99	1.75	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	188.95	3.56	0.23	0.69	0.11
Mast cell, expanded, donor8	11941-126A6	136.07	2.18	1.00	0.50	0.50
Melanocyte - dark, donor1	11502-119F8	204.97	3.28	0.99	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	161.97	2.42	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	164.44	4.64	2.75	0.22	0.00
Melanocyte - light, donor1	11274-116H5	183.12	5.17	1.65	0.71	0.47
Melanocyte - light, donor2	11351-117H1	318.71	0.68	2.05	2.05	2.05
Melanocyte - light, donor3	11423-118G1	176.05	6.07	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	185.45	1.98	1.87	0.31	0.94
Melanocyte, donor2 (MC+2)	12739-135I3	138.24	2.69	0.54	0.81	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	241.07	2.14	1.61	1.07	0.80
Meningeal Cells, donor1	11493-119E8	286.83	3.85	1.49	0.62	0.25
Meningeal Cells, donor2	11573-120E7	261.45	2.20	0.44	1.32	2.20
Meningeal Cells, donor3	11654-122E7	226.49	5.71	2.61	0.90	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	213.01	3.71	2.00	1.71	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	112.41	1.81	2.42	1.51	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	479.67	3.94	6.57	2.63	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	266.86	1.31	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	172.94	6.46	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	146.54	1.27	1.48	2.12	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	142.75	0.00	1.01	2.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	304.36	4.61	4.18	1.10	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	214.79	2.19	2.19	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	267.42	3.48	2.46	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	127.98	1.25	0.69	2.49	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	231.96	2.60	2.23	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	122.10	2.76	1.32	1.32	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	137.39	0.89	1.48	1.78	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	186.84	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	166.50	2.56	1.28	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	159.15	2.48	1.06	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	86.00	3.44	1.56	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	225.69	4.35	1.45	2.18	1.45
Mesothelial Cells, donor1	11247-116E5	133.12	3.18	1.86	2.65	0.00
Mesothelial Cells, donor2	12156-128G5	147.14	4.50	1.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	143.30	1.88	2.02	0.94	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	72.92	5.40	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	132.50	2.71	1.72	1.23	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	113.96	1.47	2.06	0.59	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	104.14	3.72	0.93	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	113.47	2.70	2.07	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	129.39	5.01	2.75	1.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	107.06	2.33	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	125.38	4.47	3.05	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	108.49	2.38	1.58	1.98	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	148.67	2.65	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	145.14	2.28	1.52	1.52	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	117.78	2.97	2.12	1.49	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	55.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	105.81	2.98	0.89	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	113.41	2.01	1.25	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	96.97	2.61	1.66	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	103.61	1.84	1.38	1.15	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	83.71	4.21	1.47	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	80.51	1.63	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	108.13	2.79	1.50	1.07	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	90.25	1.56	0.89	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	81.47	1.53	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	63.37	2.53	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	77.19	1.90	0.54	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	68.82	1.76	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	126.39	3.36	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	68.04	3.60	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	24.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	123.64	4.51	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	79.26	0.88	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	30.90	2.21	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	73.63	2.23	1.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	33.40	2.78	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	89.91	0.68	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.82	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.89	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	82.76	4.77	0.56	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	39.48	1.25	1.25	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	17.48	1.75	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	63.35	3.02	0.30	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	77.22	1.67	0.42	2.09	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	41.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	71.14	0.57	0.57	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	37.59	1.38	0.41	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	78.00	3.11	0.26	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	69.07	3.00	1.72	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	21.60	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	45.90	1.60	0.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	100.28	0.90	0.60	1.50	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.64	1.55	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	82.49	3.19	0.96	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	81.82	1.77	1.33	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.64	1.14	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	71.88	0.85	0.57	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	89.72	1.97	1.72	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	25.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	80.56	1.76	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	110.72	4.61	1.15	1.73	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	84.90	2.06	2.06	2.06	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	92.91	2.38	0.60	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	184.58	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	144.36	3.56	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	149.83	4.27	0.00	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	212.49	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	114.66	0.99	0.40	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	84.75	0.93	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	98.39	1.50	0.00	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	172.32	4.53	1.07	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	96.02	1.36	0.45	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	93.56	0.00	1.47	2.21	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	130.81	3.66	1.10	1.47	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	132.23	3.11	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	91.39	1.60	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	119.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	150.48	2.02	4.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	115.53	4.22	0.42	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	65.37	5.45	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	109.36	7.63	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	117.43	4.05	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	58.91	4.53	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	6.52	0.00	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	184.63	4.74	2.80	2.37	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	155.74	2.61	1.05	2.61	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	150.18	0.67	0.67	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	90.15	2.50	0.42	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.13	2.28	0.38	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	130.86	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	86.35	2.04	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	99.61	0.84	1.67	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	113.66	4.65	1.39	3.02	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	96.74	1.08	1.62	1.35	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	122.36	2.10	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	150.40	2.48	1.49	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	59.55	1.62	0.54	1.89	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	107.45	2.04	1.36	3.85	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	70.22	0.49	0.49	1.31	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	106.25	1.64	0.91	1.64	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	112.45	1.59	0.53	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	96.65	0.60	0.60	1.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.02	0.33	0.33	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	73.02	1.63	1.46	0.81	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	88.72	0.88	0.71	1.41	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	82.28	1.41	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	79.53	0.92	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	88.69	1.61	1.29	2.25	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.73	1.38	0.69	2.07	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	80.87	1.11	0.89	2.23	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	66.05	2.12	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	52.69	2.14	0.00	1.42	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	109.03	3.86	1.72	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	90.97	0.67	0.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	77.55	2.25	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	80.55	0.79	1.59	0.79	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	99.37	1.86	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	76.05	2.27	0.00	2.27	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	95.81	1.63	0.65	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	66.68	0.87	0.87	1.74	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	76.44	0.90	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	93.48	0.88	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	79.78	0.66	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	118.55	1.49	0.99	0.50	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	86.14	2.30	1.91	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	72.28	1.21	0.60	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	94.38	0.66	0.66	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	91.48	2.71	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	106.08	0.61	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	72.39	1.57	0.31	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	74.15	1.82	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	121.04	0.79	0.00	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	44.21	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	115.41	2.11	2.11	1.24	0.00
Myoblast, donor2	11322-117D8	137.32	2.49	1.53	1.53	0.77
Myoblast, donor3	11398-118D3	146.30	4.04	2.19	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	204.74	3.79	0.58	1.02	0.29
Natural Killer Cells, donor1	11230-116C6	76.26	0.92	0.92	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	50.36	0.30	0.00	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	60.00	1.66	0.18	0.74	0.00
Neural stem cells, donor1	11275-116H6	197.44	2.90	1.09	1.45	0.00
Neural stem cells, donor2	11352-117H2	223.37	9.63	0.00	1.93	0.00
Neurons, donor1	11494-119E9	243.51	4.55	2.28	1.14	0.00
Neurons, donor2	11574-120E8	248.12	4.40	1.32	1.10	0.22
Neurons, donor3	11655-122E8	185.81	4.11	2.47	0.82	0.82
Neutrophils, donor1	11233-116C9	9.28	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	5.50	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	106.62	1.19	0.83	1.19	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	175.17	1.30	0.33	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	163.45	0.60	1.20	2.81	0.40
Olfactory epithelial cells, donor1	11933-125I7	90.71	0.96	1.51	0.69	0.00
Olfactory epithelial cells, donor2	11934-125I8	115.07	3.18	1.30	2.17	1.45
Olfactory epithelial cells, donor3	11935-125I9	107.38	2.04	0.91	1.93	0.34
Olfactory epithelial cells, donor4	11936-126A1	123.01	1.07	1.36	0.78	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	188.97	1.20	3.01	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	113.58	3.83	0.64	1.91	0.00
Osteoblast - differentiated, donor2	11353-117H3	137.17	3.43	1.14	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	147.11	2.48	2.48	1.86	0.62
Osteoblast, donor1	11277-116H8	373.28	6.25	4.69	3.13	0.20
Osteoblast, donor2	11354-117H4	202.97	4.21	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	195.15	4.62	1.42	1.42	0.71
Pancreatic stromal cells, donor1	11249-116E7	113.80	2.61	0.84	0.84	0.42
Pericytes, donor1	11491-119E6	280.50	3.23	1.67	1.89	0.33
Pericytes, donor2	11571-120E5	199.20	2.04	0.68	1.58	0.45
Pericytes, donor3	11652-122E5	153.60	3.66	1.42	1.22	0.20
Perineurial Cells, donor1	11499-119F5	191.12	4.52	1.92	1.24	0.00
Perineurial Cells, donor2	11579-120F4	150.99	3.13	1.75	0.64	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	79.05	1.59	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	55.34	0.73	0.00	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	60.05	1.94	0.26	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	280.78	6.22	3.59	1.43	0.24
Placental Epithelial Cells, donor2	11355-117H5	312.71	2.22	0.00	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	157.06	6.28	0.98	1.96	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	137.34	1.90	0.95	1.90	1.27
Preadipocyte - breast, donor1	11467-119B9	111.05	1.13	1.31	1.31	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	43.99	0.65	0.65	0.65	0.26
Preadipocyte - breast, donor2	11328-117E5	113.70	2.25	0.68	2.03	0.45
Preadipocyte - omental, donor1	11468-119C1	106.13	2.34	1.60	1.70	0.32
Preadipocyte - omental, donor2	11329-117E6	110.86	0.44	0.44	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	128.21	3.01	2.58	1.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	149.61	1.97	1.97	3.94	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	294.83	3.38	3.07	2.46	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	210.19	2.83	1.77	0.89	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	192.59	2.21	1.87	1.02	1.19
Preadipocyte - visceral, donor1	11280-116I2	179.49	2.61	1.21	1.40	0.19
Preadipocyte - visceral, donor2	11357-117H7	163.82	1.38	0.46	2.30	2.30
Preadipocyte - visceral, donor3	11429-118G7	161.96	1.46	1.57	1.04	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	261.88	17.05	3.32	1.36	1.06
Prostate Epithelial Cells, donor2	11331-117E8	93.30	2.57	2.03	1.08	0.95
Prostate Epithelial Cells, donor3	11404-118D9	100.37	6.37	0.80	1.35	0.86
Prostate Stromal Cells, donor1	11254-116F3	122.78	2.85	1.25	1.25	0.23
Prostate Stromal Cells, donor2	11332-117E9	168.54	2.69	1.61	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	124.61	2.40	1.56	1.25	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	300.75	2.19	2.19	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	176.12	3.33	2.22	1.18	0.21
Renal Epithelial Cells, donor1	11517-119H5	587.88	6.09	4.57	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	291.64	1.42	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	204.32	4.23	1.69	1.38	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	195.40	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	186.11	0.81	0.54	1.62	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	167.17	2.89	1.55	2.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	322.07	3.33	0.67	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	302.18	4.84	1.98	2.20	0.66
Renal Mesangial Cells, donor2	11598-120H5	256.44	4.39	0.63	1.88	1.25
Renal Mesangial Cells, donor3	11679-122H5	256.61	3.05	1.66	2.77	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	297.41	3.76	1.61	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	182.59	2.53	0.42	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	269.60	2.31	1.93	1.35	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	199.13	4.41	1.81	1.56	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	204.37	2.27	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	268.60	1.03	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	152.80	4.01	0.75	1.51	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	126.42	2.67	1.74	0.94	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	118.82	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	116.68	0.00	0.00	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	90.49	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	135.88	1.04	0.52	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	167.93	2.09	0.60	1.29	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	191.18	2.12	1.23	1.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	145.75	2.73	0.00	1.36	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	190.43	2.45	0.82	1.40	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	169.42	2.08	0.00	1.16	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	155.53	1.64	0.14	0.41	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	153.54	2.72	0.91	0.91	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	188.15	3.76	0.72	0.90	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	180.04	1.86	0.43	0.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	172.13	3.33	0.86	1.61	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	169.71	2.66	0.44	0.66	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	142.24	0.96	0.19	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	154.56	3.07	0.56	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	171.00	2.25	0.19	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	138.15	1.33	0.53	0.66	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	153.80	3.21	0.29	0.78	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	169.38	3.25	0.19	1.15	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	160.40	2.46	0.53	1.07	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	150.80	1.96	0.28	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	159.79	1.37	0.85	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	150.06	0.91	0.36	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	178.31	2.94	0.61	1.35	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	176.77	2.55	0.54	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	212.29	1.65	0.00	1.42	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	171.83	2.38	0.60	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	168.14	1.17	0.23	0.94	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	199.48	1.66	0.00	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	171.22	1.99	0.44	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	141.00	2.30	0.63	1.25	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	196.90	2.15	0.13	1.62	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	122.95	2.04	0.51	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	152.89	1.35	0.96	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	189.48	2.24	0.52	0.86	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	127.02	3.02	0.14	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	147.10	2.46	0.49	0.82	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	165.83	2.05	0.34	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	162.46	4.73	0.59	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	150.33	2.93	0.00	1.60	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	141.45	1.94	0.28	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	173.81	2.62	0.48	0.95	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	173.12	3.63	1.41	1.01	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	192.21	1.22	0.28	1.22	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	161.06	1.40	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	113.63	2.72	0.30	0.91	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	208.91	2.20	0.61	1.10	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	107.71	2.33	0.44	0.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	142.37	1.22	0.61	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	196.21	0.90	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	144.76	1.36	0.68	1.13	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	147.07	1.80	0.30	1.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	139.21	1.65	0.24	1.30	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	146.21	1.28	0.00	1.28	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	138.22	2.40	0.60	2.40	0.00
Schwann Cells, donor1	11498-119F4	352.63	4.70	0.56	2.07	1.32
Schwann Cells, donor2	11578-120F3	234.77	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	223.24	4.82	1.31	1.53	1.10
Sebocyte, donor1	11220-116B5	221.30	8.76	3.29	2.74	0.00
Sebocyte, donor2	11301-117B5	175.09	7.81	4.60	0.92	1.38
Sebocyte, donor3	11378-118B1	230.02	4.33	4.12	0.41	0.62
Sertoli Cells, donor1	11255-116F4	124.24	3.31	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	107.33	2.82	0.00	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	232.17	3.70	1.67	2.20	0.53
Skeletal Muscle Cells, donor2	11358-117H8	180.71	5.78	0.72	4.34	0.00
Skeletal Muscle Cells, donor3	11430-118G8	334.42	0.84	1.67	4.18	0.84
Skeletal Muscle Cells, donor4	11451-119A2	198.10	1.26	2.67	2.20	0.63
Skeletal Muscle Cells, donor5	11455-119A6	191.90	1.64	1.49	1.34	0.59
Skeletal Muscle Cells, donor6	11459-119B1	181.30	0.92	1.85	1.69	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	170.99	0.76	2.65	1.26	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	158.67	2.85	1.85	1.85	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	197.03	2.58	2.28	1.29	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	174.49	1.60	2.36	0.42	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	248.97	6.51	1.45	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	185.90	2.20	1.10	1.65	2.48
Skin - palm, donor1	10286-104F7	48.35	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	97.31	2.16	1.87	1.87	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.98	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	109.57	1.95	1.17	0.52	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	88.27	3.48	0.97	1.25	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	68.64	4.08	0.84	0.98	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	62.80	2.75	0.42	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	80.27	5.85	1.72	1.35	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	198.73	4.01	0.93	3.39	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	49.14	0.44	0.44	1.33	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	205.74	4.70	2.94	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	127.29	3.09	1.55	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	201.62	4.33	3.15	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	194.69	4.64	2.32	4.64	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	104.08	1.00	0.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	196.29	5.72	3.06	1.46	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	138.31	3.99	0.66	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	97.82	2.18	1.28	1.66	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	156.28	2.93	1.95	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	171.29	2.66	1.77	1.77	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	121.01	2.14	1.71	0.57	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	356.42	2.93	2.93	0.98	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	101.99	1.52	1.83	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	213.67	3.28	2.27	2.02	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	166.42	4.29	1.43	3.81	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	111.64	2.21	2.21	2.06	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	147.87	2.15	0.86	1.08	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	152.82	3.15	1.26	1.47	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	191.65	5.41	1.86	1.08	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	194.02	2.16	3.23	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	114.76	2.09	1.49	1.49	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	245.81	4.10	1.37	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	93.76	1.73	0.63	1.41	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	178.44	4.63	2.31	2.11	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	122.20	1.37	1.37	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	197.45	4.83	0.00	3.62	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	180.94	2.91	1.85	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	140.35	2.26	1.33	0.80	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	127.47	2.75	0.88	2.13	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	92.59	2.54	0.51	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	151.53	3.17	2.26	1.21	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	158.29	1.50	0.00	3.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	83.99	0.00	3.88	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	214.86	2.79	4.19	2.33	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	156.51	9.09	2.52	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	138.52	4.70	1.88	2.19	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	164.90	1.77	1.47	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	157.45	4.00	1.75	1.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	130.34	1.87	1.40	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	179.03	5.47	1.30	3.02	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	211.10	6.88	1.02	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	186.72	3.76	0.75	1.32	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	138.21	4.19	1.82	1.40	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	157.35	6.12	2.09	1.26	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	325.23	7.14	1.43	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	164.41	6.36	1.96	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	130.80	1.77	0.44	2.21	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	174.38	5.27	1.46	1.76	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	72.50	0.78	0.19	1.36	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	107.63	0.53	0.53	1.59	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	67.69	0.37	0.00	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	142.66	0.00	0.72	1.44	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	182.83	1.99	0.28	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	165.03	0.39	0.79	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	74.92	1.02	0.25	1.52	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	58.70	0.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	80.26	0.84	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	89.84	0.46	0.00	2.75	0.00
Synoviocyte, donor1	11291-117A4	108.40	1.85	0.84	0.84	0.00
Synoviocyte, donor2	11368-117I9	105.44	1.51	0.84	3.02	0.17
Synoviocyte, donor3	11440-118H9	90.26	0.67	1.34	2.23	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	228.33	4.29	2.14	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	235.86	9.91	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	209.32	4.17	1.62	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	107.53	2.51	1.29	0.93	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	217.25	6.19	2.32	1.16	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	213.60	3.44	2.29	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	118.60	2.58	0.98	0.49	0.00
Urethra, donor2	10319-105A4	79.13	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	161.26	2.39	1.33	2.13	0.00
Urothelial Cells, donor2	11600-120H7	109.75	2.80	1.20	0.80	0.40
Urothelial Cells, donor3	11681-122H7	148.52	2.98	1.15	0.69	0.69
Urothelial cells, donor0	11216-116B1	140.87	3.12	1.11	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	68.51	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	57.18	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.97	2.05	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.75	0.34	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	72.63	1.74	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	73.93	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	59.66	0.92	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	56.60	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	176.04	3.95	0.99	0.86	0.12
Wilms' tumor cell line:HFWT	10597-108E3	157.53	1.76	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	239.65	7.54	1.40	0.00	0.00
achilles tendon, donor2	10292-104G4	39.26	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	152.72	3.06	1.78	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	167.63	4.41	0.70	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	187.44	4.51	0.59	0.59	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	221.50	3.27	1.63	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	210.53	1.69	1.69	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	186.10	5.08	0.42	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	140.19	1.09	0.54	1.36	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	180.66	1.76	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	188.25	1.23	1.23	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	221.33	2.33	1.16	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	237.91	4.60	2.21	0.37	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	223.32	2.09	2.09	1.16	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	231.20	3.37	1.04	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	246.07	0.29	0.58	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	105.04	1.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	193.29	1.23	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	134.44	1.84	0.61	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	239.81	7.25	0.85	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	247.18	10.62	2.12	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	256.11	12.28	2.41	0.96	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	165.49	0.89	2.00	1.11	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	169.11	3.00	1.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	273.16	5.57	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	276.09	3.39	1.13	0.38	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	163.11	0.44	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	228.68	5.62	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	181.33	3.53	0.71	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	79.73	0.62	0.62	0.00	0.16
adipose, donor1	10184-103D4	87.37	8.21	0.00	0.00	0.59
adipose, donor2	10185-103D5	116.38	8.52	0.81	1.62	2.03
adipose, donor3	10186-103D6	99.39	5.72	0.27	1.36	2.72
adipose, donor4	10187-103D7	79.74	2.60	0.00	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	278.87	6.31	1.26	1.89	0.79
adrenal gland, adult, pool1	10081-102A9	207.35	3.64	3.64	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	123.00	2.27	0.00	0.80	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	225.81	3.22	1.07	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	74.42	2.55	0.70	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	129.49	2.70	1.35	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	55.97	1.47	0.00	0.00	0.29
amygdala - adult, donor10196	10167-103B5	186.17	9.49	0.00	5.93	2.37
amygdala, adult, donor10252	10151-102I7	114.56	5.88	0.81	1.01	0.41
amygdala, newborn, donor10223	10360-105E9	79.40	0.97	0.97	1.94	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	115.87	3.69	1.66	2.42	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	189.74	2.21	2.21	1.32	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	184.05	3.34	1.00	1.00	0.33
aorta, adult, pool1	10052-101G7	79.24	1.96	0.59	1.37	0.00
appendix, adult	10189-103D9	87.33	0.78	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	171.62	1.72	0.34	1.38	0.00
artery, adult	10190-103E1	403.53	12.23	1.36	0.00	6.79
astrocytoma cell line:TM-31	10425-106D2	303.79	12.17	3.91	3.33	0.14
b cell line:RPMI1788	10427-106D4	114.05	1.93	0.30	0.74	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	108.76	4.44	1.39	1.94	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	204.91	6.55	1.98	1.49	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	123.19	3.85	2.01	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	140.37	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	96.36	1.85	0.65	0.65	0.33
blood, adult, pool1	10053-101G8	50.94	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	101.91	1.71	0.00	1.71	0.00
bone marrow, adult	10192-103E3	141.04	2.02	0.00	0.00	1.35
brain, adult, donor1	10084-102B3	154.79	9.23	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	143.76	6.01	1.11	2.12	0.11
brain, fetal, pool1	10085-102B4	144.26	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	150.65	1.98	0.00	0.00	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	286.97	13.36	2.25	3.99	0.50
breast, adult, donor1	10080-102A8	76.39	3.79	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	205.42	3.43	3.43	0.25	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	142.24	6.49	0.31	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	337.96	8.06	0.46	2.07	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	144.04	4.60	1.21	0.97	0.24
carcinoid cell line:NCI-H1770	10703-109H1	293.38	1.88	1.41	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	412.04	2.63	2.73	0.66	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	111.23	1.58	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	287.21	2.40	0.80	3.19	1.06
caudate nucleus - adult, donor10196	10177-103C6	214.15	4.61	0.00	4.61	0.00
caudate nucleus, adult, donor10252	10164-103B2	137.71	9.87	1.00	3.18	0.17
caudate nucleus, adult, donor10258	10379-105H1	304.13	6.88	0.76	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	128.18	3.30	0.37	2.20	0.37
cerebellum - adult, donor10196	10173-103C2	195.19	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	92.24	5.34	0.43	2.56	0.43
cerebellum, adult, pool1	10083-102B2	130.04	2.76	0.69	1.38	0.34
cerebellum, newborn, donor10223	10357-105E6	123.71	0.83	0.00	2.49	0.83
cerebral meninges, adult	10188-103D8	97.83	6.05	0.50	1.76	0.00
cerebrospinal fluid, donor2	10294-104G6	146.91	2.92	1.46	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	337.89	13.08	4.03	2.30	0.14
cervical cancer cell line:ME-180	10553-107I4	168.70	7.79	4.31	0.99	0.00
cervix, adult, pool1	10013-101C4	105.41	2.52	0.84	0.52	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	150.35	2.51	1.25	0.84	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	70.54	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	171.50	4.60	1.62	1.62	0.12
choriocarcinoma cell line:SCH	10785-110H2	190.86	3.33	2.59	1.23	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	193.06	11.15	1.90	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	59.55	3.42	1.14	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	129.26	4.47	1.59	1.09	0.50
chorionic membrane cells, donor3	12240-129G8	43.41	0.55	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	199.94	6.06	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	138.12	2.50	0.38	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	170.85	5.07	0.84	0.63	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	277.09	4.11	0.51	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	285.17	6.53	0.97	1.21	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	272.23	4.89	2.24	1.43	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	261.77	1.77	0.88	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	274.70	4.95	2.09	1.56	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	181.04	1.60	1.14	4.34	0.69
clear cell carcinoma cell line:TEN	10636-108I6	169.34	4.86	0.69	1.74	0.69
colon carcinoma cell line:CACO-2	10513-107D9	304.76	8.05	2.01	2.75	0.37
colon carcinoma cell line:COLO-320	10420-106C6	245.91	3.42	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	176.12	5.95	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	151.58	2.82	2.23	0.47	0.24
colon, fetal, donor1	10070-101I7	56.24	1.85	0.62	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	114.31	2.55	0.85	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	167.08	2.57	1.66	1.21	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	183.88	1.69	2.40	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	147.82	5.31	1.00	0.44	0.11
cruciate ligament, donor2	10295-104G7	43.77	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	280.09	2.41	1.61	0.00	0.00
diencephalon, adult	10193-103E4	159.35	6.96	0.48	2.16	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	131.11	1.15	1.15	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	280.54	2.82	2.56	1.80	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	122.29	2.17	4.57	1.20	0.00
ductus deferens, adult	10196-103E7	141.53	1.50	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	135.38	2.88	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	130.95	1.47	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	100.51	3.80	0.83	0.41	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	177.44	4.22	1.78	4.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	259.50	3.58	3.44	1.58	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	99.89	1.23	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	113.21	1.21	1.51	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	118.87	1.85	0.62	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	157.62	5.25	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	234.30	1.68	2.01	3.02	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	187.03	7.43	0.18	1.27	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	198.12	1.61	1.45	4.02	1.13
epidermoid carcinoma cell line:A431	10426-106D3	150.95	3.56	3.89	1.67	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	244.28	8.03	3.52	1.65	0.11
epididymis, adult	10197-103E8	86.45	2.72	0.63	0.63	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	204.20	5.68	1.24	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	174.99	2.75	0.39	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	358.81	12.19	2.36	3.54	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	340.73	9.05	1.97	2.36	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	394.34	10.42	4.59	3.02	1.57
esophagus, adult, pool1	10015-101C6	138.56	2.55	1.27	1.06	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	228.05	2.88	1.25	0.63	0.00
eye - muscle inferior rectus, donor1	10272-104E2	118.31	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	235.67	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	135.43	5.95	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	121.53	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	43.72	2.91	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	116.19	9.15	0.25	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	121.04	2.95	1.15	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	245.97	4.04	1.90	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	156.22	6.00	1.31	2.35	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	191.26	6.91	1.20	2.10	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	252.27	8.96	2.65	1.37	0.00
gall bladder, adult	10198-103E9	123.13	1.69	1.45	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	166.96	2.15	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	121.76	2.61	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	149.96	1.27	2.53	1.48	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	406.95	8.90	1.93	1.55	0.39
gastric cancer cell line:AZ521	10549-107H9	317.09	1.31	2.46	2.46	0.00
gastric cancer cell line:GSS	10560-108A2	211.42	1.83	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	171.80	2.51	0.91	0.46	0.69
giant cell carcinoma cell line:LU65	10487-107B1	105.33	5.28	0.80	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	94.19	0.84	1.12	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	307.28	5.74	2.99	2.49	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	188.52	1.90	2.85	0.95	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	168.25	3.65	1.12	1.12	0.14
glioblastoma cell line:T98G	10485-107A8	218.87	2.76	2.21	1.10	0.22
glioma cell line:GI-1	10413-106B8	204.72	1.76	1.17	2.93	0.00
globus pallidus - adult, donor10196	10175-103C4	126.83	2.19	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	117.41	6.83	0.49	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	127.34	2.74	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	112.98	2.66	0.53	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	34.26	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	185.78	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	203.84	15.68	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	118.40	1.60	0.96	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	187.78	3.21	0.00	0.92	0.92
hIPS +CCl2, biol_rep2	14384-156C1	217.20	0.91	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	255.06	0.64	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	248.65	0.00	1.44	1.44	2.87
hIPS, biol_rep2	14381-156B7	225.65	1.37	0.00	2.06	0.69
hIPS, biol_rep3	14382-156B8	201.93	3.31	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	135.05	0.00	0.86	0.86	0.00
heart - mitral valve, adult	10205-103F7	133.64	6.58	1.49	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	265.14	7.58	2.88	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	70.77	1.67	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	317.10	12.86	2.45	1.63	0.61
heart, adult, diseased, donor1	10051-101G6	544.64	25.12	4.68	3.41	2.13
heart, adult, pool1	10016-101C7	304.26	10.12	4.60	2.30	0.46
heart, fetal, pool1	10046-101G1	358.97	13.66	1.64	1.13	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	94.10	2.47	0.62	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	82.05	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	165.52	4.42	1.77	1.66	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	164.58	4.73	2.67	2.31	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	169.47	3.03	2.43	1.31	0.71
hepatoma cell line:Li-7	10484-107A7	171.94	4.45	0.67	0.44	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	189.04	4.02	2.01	0.80	0.10
hippocampus - adult, donor10196	10169-103B7	117.34	1.89	0.00	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	115.52	6.33	0.41	1.84	0.41
hippocampus, adult, donor10258	10374-105G5	163.83	1.99	0.00	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	86.71	0.70	0.00	3.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	172.12	3.05	0.00	0.00	4.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	222.86	1.37	1.57	0.59	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	224.95	1.78	4.06	0.76	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	203.55	5.07	0.56	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	191.85	9.30	0.52	0.26	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	261.55	5.31	0.38	1.90	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	122.04	4.09	0.00	1.46	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	125.59	7.32	0.43	0.43	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	169.33	5.84	1.25	2.50	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	188.01	7.10	0.24	1.18	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	168.75	5.95	0.64	1.61	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	185.83	6.73	1.35	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	197.17	2.97	2.35	1.10	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	194.55	2.95	0.98	2.95	5.40
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	121.31	0.87	0.00	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	241.50	8.97	1.34	1.15	2.48
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	213.24	8.72	1.31	1.31	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	158.92	4.00	0.00	0.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	150.15	10.93	0.19	1.88	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	162.33	14.55	0.45	3.64	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	148.16	9.40	1.57	1.88	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	167.87	8.49	0.82	1.14	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	170.99	6.39	0.87	2.61	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	169.49	5.98	0.30	1.79	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	230.38	3.69	2.40	1.48	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	223.38	2.28	1.43	0.86	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	202.93	2.86	0.82	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	195.76	3.52	1.76	1.41	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	198.60	4.43	2.53	0.95	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	248.15	7.26	0.00	0.91	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	157.21	9.31	0.52	2.07	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	167.37	6.64	0.00	1.33	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	178.55	4.36	0.26	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	170.52	5.37	0.51	0.77	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	210.51	6.82	1.51	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	175.76	3.70	0.34	0.00	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	237.88	2.90	1.45	0.72	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	196.54	1.78	0.89	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	215.61	1.95	1.46	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	235.33	5.50	0.61	0.31	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	94.34	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	185.00	5.30	0.33	0.33	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	175.14	9.85	0.00	0.55	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	147.29	6.15	0.00	1.45	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	151.25	3.56	0.36	0.71	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	170.65	3.58	0.00	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	164.00	7.72	0.27	1.08	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	139.82	5.12	0.27	0.54	0.54
immature langerhans cells, donor1	11904-125F5	21.55	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	35.65	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	183.78	6.91	1.04	3.31	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	121.28	3.25	4.88	0.65	0.00
kidney, adult, pool1	10017-101C8	275.25	4.81	3.30	0.30	0.70
kidney, fetal, pool1	10045-101F9	222.53	5.16	1.13	0.35	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	217.43	4.40	1.70	1.56	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	117.37	3.18	0.41	0.97	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	169.92	8.99	1.47	1.83	0.00
left atrium, adult, donor1	10079-102A7	266.98	11.99	1.63	0.54	1.63
left ventricle, adult, donor1	10078-102A6	299.85	8.60	3.03	0.51	2.02
leiomyoblastoma cell line:G-402	10721-110A1	188.24	2.74	1.37	1.92	0.00
leiomyoma cell line:10964C	10569-108B2	98.08	3.23	0.72	1.80	0.36
leiomyoma cell line:15242A	10570-108B3	100.54	2.17	1.09	1.09	3.26
leiomyoma cell line:15425	10571-108B4	108.54	4.37	1.21	2.43	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	124.42	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	184.52	1.89	2.13	0.71	0.12
liposarcoma cell line:KMLS-1	10782-110G8	116.38	1.72	0.31	1.72	0.00
liposarcoma cell line:SW 872	10726-110A6	179.23	2.68	1.46	2.56	0.24
liver, adult, pool1	10018-101C9	197.23	3.40	3.73	0.81	0.97
liver, fetal, pool1	10086-102B5	97.83	2.82	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	94.35	2.92	0.29	1.31	0.29
locus coeruleus, adult, donor10252	10165-103B3	108.33	5.35	0.37	2.40	0.92
locus coeruleus, adult, donor10258	10375-105G6	148.12	5.92	0.28	2.82	0.28
locus coeruleus, newborn, donor10223	10362-105F2	75.29	3.36	0.42	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	147.67	3.60	1.11	1.11	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	290.24	3.45	2.07	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	278.92	2.77	3.30	2.37	0.53
lung, adult, pool1	10019-101D1	107.02	3.19	0.83	0.35	0.00
lung, fetal, donor1	10068-101I5	80.48	0.86	0.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	67.82	2.29	0.46	0.00	0.92
lymph node, adult, donor1	10077-102A5	80.94	2.37	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	112.00	1.75	0.22	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	196.20	5.58	0.45	0.45	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	219.17	14.44	0.85	1.70	0.85
mature adipocyte, donor1	12231-129F8	146.96	2.66	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	162.70	3.11	1.25	0.21	0.21
mature adipocyte, donor3	12233-129G1	127.30	6.16	0.71	0.24	0.24
mature adipocyte, donor4	12234-129G2	143.72	3.16	1.05	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	110.55	4.29	0.95	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	160.18	3.38	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	110.53	4.41	0.74	1.47	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	167.74	3.18	0.00	2.54	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	46.49	1.28	0.00	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	154.07	3.38	0.34	3.04	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	116.94	6.37	0.64	1.49	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	156.03	1.93	0.00	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	108.04	1.44	0.36	1.44	0.72
medulla oblongata - adult, donor10196	10174-103C3	113.57	1.30	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	115.95	4.18	0.93	0.77	0.00
medulla oblongata, adult, pool1	10038-101F2	134.85	4.49	1.39	3.02	0.08
medulla oblongata, newborn, donor10223	10361-105F1	97.91	0.00	0.00	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	191.30	1.55	0.66	0.66	0.66
medulloblastoma cell line:ONS-76	10759-110E3	172.77	3.79	1.71	1.22	0.00
melanoma cell line:COLO 679	10514-107E1	124.20	1.72	1.15	0.14	0.00
melanoma cell line:G-361	10465-106H6	109.67	2.99	0.27	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	184.16	5.61	2.53	2.17	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	348.94	2.64	1.76	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	262.85	3.11	0.78	0.78	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	170.16	2.30	1.23	1.23	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	111.98	1.64	0.73	1.27	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	140.79	0.83	1.24	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	122.35	1.69	0.98	1.12	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	128.64	1.35	1.93	1.35	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	123.55	2.78	0.00	6.94	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	123.58	1.72	1.20	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	103.05	2.19	1.73	1.73	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	133.96	1.72	0.93	1.19	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	110.87	2.57	1.35	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	96.17	1.56	1.14	1.14	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	104.08	1.98	0.33	1.32	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	129.24	1.94	1.11	2.08	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	143.12	1.05	1.40	1.40	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	92.89	1.43	0.82	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	104.24	1.44	0.00	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	106.04	1.86	0.83	1.34	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	108.98	2.28	2.96	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	76.78	0.84	0.84	2.94	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	130.16	1.20	0.75	1.49	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	127.36	2.54	1.05	1.84	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	115.97	0.37	0.74	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	93.57	0.57	0.00	2.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	158.30	0.84	1.26	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	129.69	1.83	0.91	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	137.87	2.56	1.28	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	153.39	3.40	0.26	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	138.33	2.16	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	124.03	1.41	0.71	1.18	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	130.64	2.37	0.68	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	137.54	0.79	0.39	2.75	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	133.92	1.85	0.46	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	149.69	2.88	1.44	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	138.77	2.90	0.45	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	144.45	1.44	0.72	2.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	132.73	2.93	0.73	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	133.93	2.35	1.01	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	140.83	2.05	0.82	2.87	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	142.18	1.72	0.00	2.15	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	177.74	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	139.45	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	112.70	2.60	1.95	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	139.68	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	133.80	4.80	1.07	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	103.86	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	121.28	2.33	0.78	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	104.94	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	119.22	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	143.02	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	112.07	1.19	0.00	1.78	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	141.34	0.00	4.87	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	243.47	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	131.74	2.53	1.27	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	91.74	0.69	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	96.71	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	86.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	83.12	0.81	0.00	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	93.74	0.79	0.79	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	79.59	0.59	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	79.48	0.31	0.31	1.56	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	76.19	1.34	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	167.94	0.00	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	179.76	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	165.22	2.07	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	311.23	1.98	0.99	0.49	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	289.35	1.12	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	293.86	3.18	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	452.15	6.04	2.82	1.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	414.31	4.36	2.18	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	391.52	1.27	2.53	3.80	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	275.53	2.43	1.21	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	379.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	318.76	3.29	0.82	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	136.72	1.19	0.79	0.99	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	161.92	3.24	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	182.33	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	57.25	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	211.67	2.13	2.83	2.83	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	168.43	5.10	2.32	4.40	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	162.40	4.27	8.55	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	71.21	1.34	0.62	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	138.44	2.50	3.63	0.68	0.45
mesothelioma cell line:Mero-41	10851-111F5	201.45	3.18	0.98	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	218.77	2.21	1.33	3.10	0.22
mesothelioma cell line:Mero-82	10853-111F7	187.38	2.10	2.10	2.37	0.79
mesothelioma cell line:Mero-83	10854-111F8	171.07	0.17	2.72	1.36	0.00
mesothelioma cell line:Mero-84	10855-111F9	262.63	2.02	1.77	2.27	0.25
mesothelioma cell line:Mero-95	10856-111G1	167.29	0.83	1.66	1.45	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	257.75	3.15	3.15	1.49	0.99
mesothelioma cell line:NCI-H226	10846-111E9	226.96	2.17	3.80	1.45	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	249.40	1.88	3.25	1.88	0.51
mesothelioma cell line:NCI-H28	10845-111E8	154.21	1.53	1.27	1.78	0.51
mesothelioma cell line:No36	10857-111G2	193.76	3.26	1.63	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	221.91	0.81	1.35	3.25	1.08
migratory langerhans cells, donor1	11901-125F2	60.84	1.92	0.19	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	79.50	1.95	0.61	0.12	0.49
migratory langerhans cells, donor3	11903-125F4	91.00	3.95	0.00	0.54	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	218.41	5.88	0.65	2.29	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	145.39	7.21	0.85	5.51	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	224.83	4.38	1.15	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	124.07	2.09	0.57	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	210.11	6.10	0.92	0.55	0.18
myeloma cell line:PCM6	10474-106I6	127.50	3.95	1.19	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	164.87	1.52	2.03	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	564.49	9.41	3.53	6.08	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	141.73	8.58	1.34	2.67	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	121.34	8.90	1.25	2.13	0.22
nasal epithelial cells, donor2	12227-129F4	91.08	2.76	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	215.34	3.45	0.69	2.07	0.23
neuroblastoma cell line:NB-1	10539-107G8	242.65	2.99	0.75	1.68	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	450.88	7.17	2.11	4.43	0.84
neuroblastoma cell line:NH-12	10555-107I6	237.22	3.54	0.93	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	126.92	0.95	0.24	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	125.28	3.96	1.58	0.32	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	301.49	6.84	1.41	0.60	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	178.01	2.54	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	116.85	2.13	1.06	1.33	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	125.99	3.04	0.68	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	218.54	3.20	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	121.83	2.89	0.64	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	126.92	2.36	0.53	1.84	0.53
nucleus accumbens, adult, pool1	10037-101F1	211.29	8.91	1.78	4.12	0.00
occipital cortex - adult, donor10196	10172-103C1	189.56	2.06	0.00	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	105.47	5.90	0.54	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	119.37	1.82	0.73	2.91	0.36
occipital lobe, adult, donor1	10076-102A4	151.40	6.56	1.84	2.10	1.05
occipital lobe, fetal, donor1	10073-102A1	119.72	4.29	0.00	1.72	0.00
occipital pole, adult, pool1	10036-101E9	242.04	7.33	2.05	2.37	0.16
olfactory region, adult	10195-103E6	120.94	5.73	0.57	1.72	0.00
optic nerve, donor1	10277-104E7	100.05	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	172.46	3.76	2.73	3.30	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	221.19	6.59	2.20	3.71	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	169.15	4.74	2.37	0.68	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	228.59	5.89	1.96	1.73	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	96.42	2.94	0.88	2.06	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	408.30	5.61	6.54	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	111.76	1.91	0.21	0.42	0.00
ovary, adult, pool1	10020-101D2	107.27	3.23	1.66	0.79	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	71.31	2.38	0.37	0.73	0.00
pancreas, adult, donor1	10049-101G4	171.20	6.58	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	101.19	3.07	1.12	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	186.88	6.13	1.19	1.19	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.71	3.81	1.32	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	190.73	6.77	1.65	3.29	0.09
parietal cortex, adult, donor10258	10373-105G4	191.58	1.47	0.00	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	152.36	0.94	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	105.18	2.85	0.00	2.57	0.29
parietal lobe, adult, pool1	10034-101E7	185.84	6.43	1.06	2.73	0.26
parietal lobe, fetal, donor1	10072-101I9	128.02	5.82	0.97	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	107.30	0.75	0.00	2.62	0.75
parotid gland, adult	10199-103F1	167.73	1.23	0.62	0.62	0.62
penis, adult	10200-103F2	165.43	4.30	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	106.36	1.67	0.19	0.56	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	475.55	12.82	4.23	1.60	0.87
pineal gland - adult, donor10196	10179-103C8	98.04	6.45	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	114.89	4.74	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	102.84	3.76	0.63	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	224.62	4.05	2.02	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	170.43	7.82	0.52	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	180.46	4.26	0.00	2.55	2.55
placenta, adult, pool1	10021-101D3	91.16	1.72	0.32	0.43	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	106.74	2.78	0.26	0.79	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	455.25	15.56	4.05	4.20	0.93
pons, adult, pool1	10033-101E6	149.33	4.22	0.95	3.44	0.00
postcentral gyrus, adult, pool1	10032-101E5	224.56	8.89	1.74	4.18	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	170.75	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	265.54	5.24	1.89	3.64	0.87
prostate cancer cell line:PC-3	10439-106E7	300.57	10.53	3.27	6.90	0.36
prostate, adult, pool1	10022-101D4	102.03	2.81	0.63	1.72	0.18
putamen, adult, donor10196	10176-103C5	241.97	9.68	2.12	4.72	0.94
putamen, adult, donor10252	10152-102I8	131.37	1.96	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	231.68	3.28	0.00	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	257.32	7.49	0.72	2.17	0.00
putamen, newborn, donor10223	10365-105F5	74.22	1.50	0.00	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	116.08	4.07	0.87	1.45	0.00
rectum, fetal, donor1	10067-101I4	129.36	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	168.75	3.60	1.27	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	74.56	1.24	0.41	2.49	0.41
retina, adult, pool1	10030-101E3	201.48	9.05	0.60	1.19	0.10
retinoblastoma cell line:Y79	10475-106I7	212.78	1.82	0.78	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	187.87	2.58	1.11	1.23	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	309.32	1.97	1.97	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	100.79	1.52	0.76	3.03	0.00
salivary acinar cells, donor1	11771-123I7	97.28	1.62	0.97	1.13	0.16
salivary acinar cells, donor2	11772-123I8	91.56	1.65	0.14	0.55	0.69
salivary acinar cells, donor3	11773-123I9	62.89	0.66	1.32	0.66	0.66
salivary gland, adult, pool1	10093-102C3	234.50	3.43	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	124.28	2.61	1.26	2.53	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	106.27	2.12	1.29	1.53	0.00
seminal vesicle, adult	10201-103F3	141.79	1.59	0.53	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	106.64	1.70	0.73	1.21	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	156.52	0.25	2.01	1.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	286.01	2.01	2.01	2.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	120.89	1.48	2.28	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	184.14	3.98	0.99	0.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	179.22	2.71	1.16	1.29	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	361.05	7.09	0.71	0.00	3.55
skeletal muscle, adult, pool1	10023-101D5	297.20	9.95	2.40	1.44	0.60
skeletal muscle, fetal, donor1	10066-101I3	156.78	6.03	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	115.35	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	111.10	3.16	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	240.14	4.00	1.33	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	209.30	1.89	0.32	1.26	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	1866.76	22.55	4.63	8.10	7.32
small cell lung carcinoma cell line:LK-2	10541-107H1	181.80	2.64	0.49	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	153.93	1.93	0.16	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	391.60	4.36	1.09	0.65	0.22
small intestine, adult, pool1	10024-101D6	179.76	4.54	0.96	0.36	0.36
small intestine, fetal, donor1	10064-101I1	122.36	3.69	0.00	0.98	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	121.56	3.59	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	92.27	2.58	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	179.84	1.88	0.54	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	87.86	1.61	0.69	1.61	0.00
spinal cord, adult, donor10252	10159-103A6	76.88	1.18	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	89.93	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	123.19	4.27	0.00	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	69.80	1.84	0.00	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	114.55	3.14	1.34	0.75	0.15
spleen, adult, pool1	10025-101D7	105.18	3.19	0.33	0.11	0.22
spleen, fetal, pool1	10044-101F8	99.64	2.22	0.79	0.24	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	87.05	2.79	0.41	0.52	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	139.56	3.42	1.71	1.33	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	282.36	7.34	2.80	3.15	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	95.39	4.30	0.78	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	190.00	15.42	3.26	0.90	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	142.75	2.54	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	170.50	1.27	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	102.53	5.34	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	146.41	3.42	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	108.21	5.61	0.62	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	203.80	2.59	0.00	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	60.77	0.71	0.00	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	113.94	2.98	0.46	0.92	0.00
temporal lobe, adult, pool1	10031-101E4	231.93	9.75	2.71	4.24	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	126.78	1.42	2.85	2.14	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	159.55	1.32	0.44	1.76	0.44
tenocyte, donor1	11763-123H8	167.22	1.75	1.75	0.35	1.05
tenocyte, donor2	11765-123I1	97.67	2.29	0.76	1.91	1.14
tenocyte, donor3	11768-123I4	141.59	1.11	1.11	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	193.08	2.72	1.70	2.04	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	168.48	2.77	2.16	0.62	0.31
teratocarcinoma cell line:PA-1	10807-111A6	208.91	4.65	1.86	0.62	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	173.54	1.52	1.27	2.41	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	191.73	1.51	1.89	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	106.12	0.98	0.65	0.65	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	79.47	1.95	1.30	0.33	0.98
testis, adult, pool1	10026-101D8	121.98	12.35	1.40	22.23	0.75
testis, adult, pool2	10096-102C6	135.33	13.08	0.90	43.76	1.35
thalamus - adult, donor10196	10168-103B6	120.33	1.10	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	114.24	2.66	0.47	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	240.18	0.00	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	127.47	4.12	0.33	2.31	0.16
thalamus, newborn, donor10223	10366-105F6	74.79	1.73	0.58	1.73	0.00
throat, adult	10209-103G2	191.75	5.49	1.00	0.50	1.25
throat, fetal, donor1	10061-101H7	110.30	6.70	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	240.27	1.59	1.19	2.19	0.20
thymus, adult, pool1	10027-101D9	170.79	4.08	1.39	0.20	0.70
thymus, fetal, pool1	10043-101F7	119.18	3.12	0.42	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	140.94	2.26	3.19	1.06	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	248.65	5.59	1.26	1.26	0.28
thyroid, adult, pool1	10028-101E1	172.91	8.77	2.15	0.84	0.28
thyroid, fetal, donor1	10060-101H6	131.30	6.86	0.26	0.79	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	249.56	7.68	1.16	1.16	2.79
tongue, fetal, donor1	10059-101H5	311.33	18.52	0.79	0.39	1.18
tonsil, adult, pool1	10047-101G2	158.38	4.51	1.30	0.50	0.10
trachea, adult, pool1	10029-101E2	113.95	3.68	0.82	0.65	0.08
trachea, fetal, donor1	10058-101H4	115.02	3.85	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	121.87	1.77	2.48	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	226.14	4.76	1.72	1.22	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	167.66	1.57	1.57	1.41	0.47
tridermal teratoma cell line:HGRT	10694-109G1	93.22	3.81	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	285.27	7.20	2.88	2.37	0.42
umbilical cord, fetal, donor1	10057-101H3	169.01	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	101.52	1.37	0.00	1.02	0.00
uterus, fetal, donor1	10055-101H1	98.80	2.05	0.51	1.02	0.51
vagina, adult	10204-103F6	72.37	0.65	0.00	0.00	0.65
vein, adult	10191-103E2	99.74	1.97	0.44	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	106.81	5.07	0.80	1.07	0.00